CPHI’s Post

🌟 Exciting News! 🌟 Pharma West Africa is just around the corner, happening from March 20th to 22nd at the Landmark Centre, Nigeria! But why should you be part of Pharma West Africa? Here's why: 🔬 Connect with Industry Leaders: Meet over 150 exhibitors showcasing groundbreaking pharmaceutical products and technologies. It's your chance to see what's shaping the future of healthcare. 🌍 Network with Professionals: Join over 2,500 peers from the West African pharmaceutical industry. 💡 Learn and Grow: Attend our insightful conferences and seminars. Expand your knowledge and stay ahead of the curve in this rapidly evolving industry. 🤝 Forge New Partnerships: Discover new suppliers, buyers, and collaborators. Pharma West Africa is the perfect platform to build lasting business relationships. 🚀 Boost Your Business: With all industry stakeholders under one roof, the opportunities for growing your business are endless. Don't miss out on this incredible event. Pharma West Africa is more than just a conference; it's a gateway to the future of the pharmaceutical industry in West Africa. Register your FREE attendance: https://lnkd.in/ea2XvK-t See you there! #PharmaWestAfrica2024 #HealthcareInnovation #NetworkingOpportunity 🌐💊🔗

It is an interesting time to be in the Middle East and, nearly on a daily basis, I hear about the exciting energy coming from Saudi Arabia when it comes to Healthcare and Life Sciences. Saudi Arabia is set to revolutionize its healthcare and pharmaceutical sectors, embracing innovation and sustainability. Here's how: 🚀 Vision 2030 is Propelling Saudi Arabia: the Kingdom aims to provide inclusive health services and integrate a digital medical records system by 2025. 🌍 MENA’s Pharmaceutical Powerhouse: As the largest pharmaceutical market in the region providing accelerated regulatory pathways and innovative pricing mechanisms such as value-based contracting, the Kingdom sparks interest in many MNCs. 📈 Local Manufacturing on the Rise: the Saudi government targets to localize 40% of the pharmaceutical sector, addressing both biologics and generics needs internally. 🚑 Universal Health Coverage Goals: with a growing elderly population and increase of NCDs, the initiative is a proactive approach to expand access to essential healthcare services. How do you think things will evolve in the near future? #ksa #pharmaceuticals #pharma #innovation #healthcare #accesstocare #LifeSciences

Introducing the Arab Pharma Expert's Association: A New Era in Pharmaceutical Excellence Distinguished colleagues and fellow pharmaceutical professionals, I am honored to announce the upcoming launch of the Arab Pharma Expert's Association, set for next October at the International Exhibition for Pharmaceuticals and Medical Equipment (IEPM) in Dubai. This event will mark a significant milestone in advancing pharmaceutical excellence in the Arab world. As a founder, I'm proud to introduce an organization born from a vision of unity, knowledge-sharing, and innovation in all fields of pharma and not only of specific field like other existing associations. We aim to foster collaboration, enhance professional standards, and drive technological advancements across the Arab pharmaceutical landscape. Our association will be built on four key pillars: Knowledge Exchange Regulatory Harmonization Innovation Promotion Professional Development To underscore our commitment, we'll inaugurate an advanced course in Good Manufacturing Practices (GMP). I invite all pharmaceutical scientists, regulatory experts, industry leaders, and policymakers to join us in shaping the future of Arab pharmaceuticals. Together, we can build a robust, innovative, and globally competitive sector that addresses our region's healthcare needs and contributes to global advancements. The launch next October isn't just the beginning of an organization; it's the start of a movement toward pharmaceutical excellence. Join us on this transformative journey as we elevate the Arab pharmaceutical industry to new heights. We look forward to welcoming you as members and partners and realizing our shared vision for the future of Arab pharmaceuticals. #ArabPharmaExperts #PharmaceuticalExcellence #IEPM2024

At the 18th SIPHAL International Pharma Exhibition in Algeria, Eddy Gilissen, Senior Director for Supplier Alliances, and Rafik Zenati, General Manager for Algeria, took the stage to discuss critical topics in the pharmaceutical industry. Eddy presented on the topic of The Shortage of Medicine in Europe, where he delved into the multifaceted factors contributing to the medicine shortage in Europe. He emphasized the growing significance of the supply chain and presented IQVIA’s research-backed solutions to address this pressing issue. #medicineshortage #supplychain Rafik spoke about the importance of e-QMS, where he highlighted the pivotal role of an e-QMS (electronic quality management system). He underscored its impact on compliance, operational efficiency, and market competitiveness. Additionally, Rafik introduced IQVIA’s cutting-edge SmartSolve #eQMS solution. Read more about the solution here; https://lnkd.in/dMdkHgFw #SIPHAL2024

On this day on 27 July 1921: A pivotal day in pharma history as Canadian doctors Frederick Banting and Charles Best successfully isolated the hormone insulin, marking a monumental breakthrough in the treatment of diabetes. Their research involved producing diabetes symptoms in the animals and then providing insulin injections that normalized blood glucose levels. This revolutionary milestone transformed diabetes treatment from a fatal diagnosis to a manageable condition and today, insulin remains one of the most significant medical breakthroughs of the 20th century. Be part of the next chapter in pharma history. Join us at CPHI Middle East to connect with industry leaders, showcase your innovations, and shape the future of healthcare. This is where the next big breakthroughs happen. 🗓 10 - 12 Dec 2024 📍 Riyadh, Saudi Arabia 🔗 Exhibit Now: https://lnkd.in/dFazGGNZ #AtTheHeartofPharma #cphime #cphi #pharmaceuticals #biotech #saudivision2030 #healthcare #pharma #pharmasupplychain #drugdiscovery #pharmaceuticalmanufacturing #medicine #lifescience #drugdelivery #sustainability #biopharma #innovationsinhealthcare #datadriven #pharmaexhibition #pharmaevent #pharmaconference #saudiarabia #riyadh #Tahaluf

BREAKING NEWS! Vertex Pharmaceuticals Casgevy becomes the first therapy to secure approval from the SFDA - هيئة الغذاء والدواء under the breakthrough medicine program, marking a significant milestone in addressing #SickleCellDisease and #TransfusionDependentBetaThalassemia in the country. The Breakthrough Medicines Program, which was launched in October 2023, is dedicated to granting patients facing life-threatening or severely debilitating conditions access to promising new medicines in as quickly as 60 working days, marking a turning point in the #SpeedToAccess in Saudi Arabia. #MedicalInnovation #CasgevyApproval #sicklecelldisease #sicklecellwarriors #Vertex #HealthcareAdvancements #SaudiArabia

Maintaining the Nordic countries as “one of the most integrated regions for medicines in Europe”—that goal was reaffirmed at a meeting of the steering group of the Nordic Pharmaceutical Forum (NPF) in Stockholm on 7th May 2024. The meeting also considered additional activities and objectives for the group in the coming years, including its role in pan-European initiatives.   Tackling antimicrobial resistance is a priority for the NPF. Health ministers in the region announced plans for closer collaboration to safeguard supplies of antibiotics, including the possibility of joint procurement. Denmark, Norway and Iceland have developed a joint tendering procedure that features criteria related to the prevention of resistance.   At EU level, the NPF is a member of the European Commission’s recently formed Critical Medicines Alliance, which has been described as “the industrial arm of a strong European Health Union.” The Forum “will contribute actively with its experience on joint Nordic tendering procedures to the Commission, which is working to identify best practices in tendering procedures. When the Commission decides on best practices, their work will result in a number of recommendations for its member countries.” #Nordic #crossbordercollaboration #jointprocurement

✨ Namaste Global Heads to CPHI North America: Bridging the Gap for Indian Healthcare in the US Market! ✨ We as Namaste Global will be attending CPHI North America, the premier pharmaceutical event, happening 07 – 09 May in Philadelphia! Our founder, 📢 Sanchit Sharma, and our team of 💊 scientific experts are eager to connect with industry leaders, explore the latest advancements in biopharma, and showcase how Namaste Global empowers Indian healthcare companies to seamlessly enter and thrive in the US market. Are you an Indian CDMO looking to expand your reach? CPHI provides the perfect platform to connect with potential US partners and unlock new growth opportunities. We understand the challenges CDMOs face in navigating the US market, and our team is here to help! At CPHI, we'll be discussing: ⭐ Strategies for Indian CDMOs to successfully enter the US market. ⭐ Building strategic partnerships with US pharmaceutical companies. ⭐ Leveraging Namaste Global's expertise to overcome regulatory hurdles and cultural differences. Connect with us! We'd love to discuss your specific needs and how Namaste Global can help you achieve your US expansion goals. Schedule your meet with us between May 7 – 9 by writing to us at info@namasteglobal.co or comment below. #CPHI #NorthAmerica #Pharma #CDMO #India #USA #Healthcare #MarketEntry #Partnerships

Yesterday, we were honoured to be a part of the EU #CriticalMedicinesAlliance launch, represented by 15 of our member CEOs.  We thank them for their commitment and dedication to ensuring a secure supply of medicines in Europe. Over 90% of the EU critical medicines list are essential, #GenericMedicines. They need dedicated policy actions to secure their supply, including: 💊A concrete shortage prevention-strategy 🤝Partnership between the EU and our industry 🔓A shared commitment to ensure access, availability and supply security based on EU solidarity. Read our vision for the EU Critical Medicines Alliance at https://lnkd.in/dG949KJN See our proposal for a critical medicine act at  https://lnkd.in/dgt65ahU Elisabeth Stampa, Medichem, S.A. - Rebecca Guntern, Sandoz - Markus Sieger, Polpharma - Steffen Saltofte, Zentiva - Philippe Drechsle, Teva Pharmaceuticals - Martha Christopoulou, Baxter International Inc. - Stephan Eder, STADA Group - Artur Cwiok, Viatris - Csaba Poroszlai, Egis Pharmaceuticals PLC - Bruno Belli, Fresenius Kabi - Lucas Sigman, Insud Pharma - THEODOROS TRYFON, Elpen Pharmaceutical Co. Inc., Πανελλήνια Ένωση Φαρμακοβιομηχανίας (ΠΕΦ) - PEF - Andreas Loizou, Medochemie Ltd Adrian van den Hoven - Giuliana Pennisi European Commission Belgian Presidency of the Council of the European Union 2024 #AccessForAll #LevellingUp

I was thrilled to be part of such crucial first step towards a Critical Medicines Act. Indeed, we need to complement the #PharmaLegislation with a strong toolkit to tackle #medicineShortages that are adversely affecting patients across Europe. Under the auspices of the European Commission President Ursula von der Leyen the Belgian Presidency of the Council of the European Union 2024 led by Frank Vandenbroucke, Deputy Prime Minister and Minister of Social Affairs and Public Health, along with Commissioner for Health Stella Kyriakides and EU 27 Ministers of Health, the EU #CriticalMedicinesAlliance was officially launched. 15 CEOs representing Medicines for Europe presented our comprehensive approach to secure medicine supplies: 💊 A concrete shortage prevention strategy that includes EU medicines procurement guidelines rewarding security of medicine supply as well as the use of existing IT systems to predict and prevent shortages (such as the serialization system). 🤝 Collaboration between the EU and industry to enhance EU manufacturing competitiveness through digital and environmental innovations in production technologies. This can be facilitated through State Aids and IPCEI initiatives for off-patent medicines. 🔓 Concrete EU 27 solidarity should be our health mantra to deliver equity of access across EU Member States. We must avoid national stockpiling mandates, as they could result in oversupply in larger countries and shortage risks in smaller ones. According to the IQVIA MIDAS database, the German 6-months stockpile is equal to 10 Member Staes annual consumption and stockpile combined (see infographic below). We are ready to further collaborate with EU Institution, Member States and health stakeholders. Action is needed now! 💪🏼 #MedsSecurity #AccessEquity #LevelUP #EUhealthUnion #EUsolidarity #EU2024BE